Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Psychemedics Corporation stock
Learn how to easily invest in Psychemedics Corporation stock.
Psychemedics Corporation is a diagnostics & research business based in the US. Psychemedics Corporation shares (PMD) are listed on the NASDAQ and all prices are listed in US Dollars. Psychemedics Corporation employs 138 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Psychemedics Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PMD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Psychemedics Corporation stock price (NASDAQ: PMD)Use our graph to track the performance of PMD stocks over time.
Psychemedics Corporation shares at a glance
|Latest market close||$7.17|
|52-week range||$4.92 - $8.84|
|50-day moving average||$7.84|
|200-day moving average||$7.42|
|Wall St. target price||$32.00|
|Dividend yield||$0 (2.65%)|
|Earnings per share (TTM)||$0.07|
Buy Psychemedics Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Psychemedics Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Psychemedics Corporation price performance over time
|1 week (2022-01-07)||-5.16%|
|1 month (2021-12-16)||0.99%|
|3 months (2021-10-15)||-14.23%|
|6 months (2021-07-16)||5.29%|
|1 year (2021-01-15)||44.85%|
|2 years (2020-01-16)||-32.49%|
|3 years (2019-01-16)||18.04|
|5 years (2017-01-13)||24.2|
Is Psychemedics Corporation stock undervalued or overvalued?
Valuing Psychemedics Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Psychemedics Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Psychemedics Corporation's P/E ratio
Psychemedics Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 105x. In other words, Psychemedics Corporation shares trade at around 105x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Psychemedics Corporation's EBITDA
Psychemedics Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.5 million.
The EBITDA is a measure of a Psychemedics Corporation's overall financial performance and is widely used to measure a its profitability.
Psychemedics Corporation financials
|Revenue TTM||$23.8 million|
|Operating margin TTM||0.27%|
|Gross profit TTM||$4.9 million|
|Return on assets TTM||0.17%|
|Return on equity TTM||3.06%|
|Market capitalisation||$41.9 million|
TTM: trailing 12 months
Psychemedics Corporation share dividends
Dividend payout ratio: 17.16% of net profits
Recently Psychemedics Corporation has paid out, on average, around 17.16% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Psychemedics Corporation shareholders could enjoy a 2.65% return on their shares, in the form of dividend payments. In Psychemedics Corporation's case, that would currently equate to about $0 per share.
While Psychemedics Corporation's payout ratio might seem low, this can signify that Psychemedics Corporation is investing more in its future growth.
Psychemedics Corporation's most recent dividend payout was on 29 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 16 December 2021 (the "ex-dividend date").
Have Psychemedics Corporation's shares ever split?
Psychemedics Corporation's shares were split on a 1:4 basis on 31 July 2002. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Psychemedics Corporation shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Psychemedics Corporation shares which in turn could have impacted Psychemedics Corporation's share price.
Psychemedics Corporation share price volatility
Over the last 12 months, Psychemedics Corporation's shares have ranged in value from as little as $4.9151 up to $8.8373. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Psychemedics Corporation's is 0.7527. This would suggest that Psychemedics Corporation's shares are less volatile than average (for this exchange).
Psychemedics Corporation overview
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts. .
Psychemedics Corporation in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda
Frequently asked questionsWhat percentage of Psychemedics Corporation is owned by insiders or institutions?
Currently 18.166% of Psychemedics Corporation shares are held by insiders and 30.494% by institutions. How many people work for Psychemedics Corporation?
Latest data suggests 138 work at Psychemedics Corporation. When does the fiscal year end for Psychemedics Corporation?
Psychemedics Corporation's fiscal year ends in December. Where is Psychemedics Corporation based?
Psychemedics Corporation's address is: 289 Great Road, Acton, MA, United States, 01720 What is Psychemedics Corporation's ISIN number?
Psychemedics Corporation's international securities identification number is: US7443752057 What is Psychemedics Corporation's CUSIP number?
Psychemedics Corporation's Committee on Uniform Securities Identification Procedures number is: 744375106
More guides on Finder
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert